The independent source for health policy research, polling, and news.
KFF’s policy research provides facts and analysis on a wide range of policy issues and public programs.
KFF designs, conducts and analyzes original public opinion and survey research on Americans’ attitudes, knowledge, and experiences with the health care system to help amplify the public’s voice in major national debates.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the organization’s core operating programs.
As the U.S. prepares for nationwide distribution of vaccines to combat COVID-19, some are asking whether people who get the first of two doses will return to complete the series. This analysis draws on Medicare Part D prescription drug claims data for the herpes zoster vaccine Shingrix, which also requires two doses, to shed light on this potential challenge of the leading COVID-19 vaccine candidates.
People 65 and older, who have been hardest hit by COVID-19 in terms of hospitalizations and deaths, are also at high risk of severe flu illness and are more likely to die of the flu than younger people. This analysis explores variation in the rate of flu vaccination among adults ages 65 and older covered by Medicare, and reasons cited for not getting vaccinated, based on data from the 2018 Medicare Current Beneficiary Survey.
A new KFF analysis examines the different approaches states are taking to manage the limited initial supply of COVID-19 vaccines and balance the desire to vaccinate those at greatest risk first with the need to ensure a fast and effective statewide vaccination effort.
This Health Policy 101 chapter explores trends in health care costs in the U.S. and the factors that contribute to this spending. It also examines how health care spending varies across the population, the impact of costs on care affordability and individuals' overall financial vulnerability.
The House approved its FY 2024 State, Foreign Operations, and Related Programs (SFOPs) appropriations bill on September 28, 2023 (the House Committee on Appropriations released the bill on June 22, 2023 and accompanying report on July 11, 2023).
President Trump has conjured up the image of a top general and the military delivering the coronavirus vaccine drawing on their vast logistical experience. In his latest Axios column, Drew Altman explains why vaccine realities will dictate that it’s much more likely to be at your local Walgreens or CVS pharmacy.
This brief answers key questions about the U.S. monkeypox outbreak to date and identifies issues that may affect the response going forward.
Updated on January 3, 2023 The FY 2023 Omnibus appropriations bill and accompanying reports, released by Congress on December 20, 2022, and signed by the President on December 29, 2022, includes funding for
This fact sheet provides a snapshot of global maternal and child health (MCH) and examines the U.S. government’s role in addressing MCH worldwide.
With hopes that a COVID-19 vaccine or vaccines will be proven safe and effective soon, state and local public health authorities will play a critical role in ensuring the efficient distribution and administration of the vaccine.
© 2026 KFF